January 2, 2018 / 1:11 PM / 9 months ago

BRIEF-Inovio Enters License, Collaboration Agreement With Apollobio To Develop, Commercialize VGX-3100 In Greater China

Jan 2 (Reuters) - Inovio Pharmaceuticals Inc:

* INOVIO ENTERS LICENSE AND COLLABORATION AGREEMENT WITH APOLLOBIO TO DEVELOP AND COMMERCIALIZE VGX-3100 IN GREATER CHINA

* INOVIO PHARMACEUTICALS INC - BASED ON NEW AGREEMENT, APOLLOBIO WILL MAKE AN UPFRONT PAYMENT OF $23 MILLION

* INOVIO PHARMACEUTICALS INC - BASED ON NEW AGREEMENT, APOLLOBIO WILL MAKE POTENTIAL FUTURE PAYMENTS UP TO $20 MILLION UPON MEETING CERTAIN MILESTONES

* INOVIO PHARMACEUTICALS INC - BASED ON NEW AGREEMENT, INOVIO IS ENTITLED TO RECEIVE DOUBLE-DIGIT TIERED ROYALTY PAYMENTS ON SALES

* INOVIO PHARMACEUTICALS - ENTERED AMENDED AGREEMENT PROVIDING APOLLOBIO WITH EXCLUSIVE RIGHT TO DEVELOP AND COMMERCIALIZE VGX-3100 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below